BioBot Analytics

BioBot Analytics

Analyzes wastewater for public health insights

About BioBot Analytics

Simplify's Rating
Why BioBot Analytics is rated
A-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated A on Rating Differentiation

Industries

Social Impact

Healthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$54.8M

Headquarters

Cambridge, Massachusetts

Founded

2017

Overview

Biobot Analytics specializes in wastewater epidemiology, which involves analyzing sewage to gather important public health data. The company serves various clients, including governments, businesses, universities, and health systems, by providing insights into community health trends such as the presence of high-risk substances and the spread of diseases. Biobot's services include regular reports and real-time data derived from wastewater samples, allowing clients to monitor and respond to health trends effectively. Unlike its competitors, Biobot focuses specifically on wastewater analysis, which has proven particularly useful during health crises like the COVID-19 pandemic. The company's goal is to enhance public health efforts and improve community well-being through actionable insights from wastewater data.

📈
Significant Headcount Growth
YC Company
💵
Funded Recently
Simplify Jobs

Simplify's Take

What believers are saying

  • Biobot secured $30 million funding to enhance its sewage analysis technology.
  • The nationwide program for high-risk substances monitoring shows strong growth potential.
  • Lieutenant General H.R. McMaster's board membership may boost national security collaborations.

What critics are saying

  • Competition from Verily in securing government contracts poses a significant challenge.
  • Over-reliance on government contracts could affect Biobot's financial stability.
  • Public skepticism about wastewater data usage may hinder widespread adoption.

What makes BioBot Analytics unique

  • Biobot transforms wastewater into public health observatories, offering unique epidemiological insights.
  • The company provides unbiased health data, independent of hospital reporting systems.
  • Biobot's technology rapidly adapts to emerging public health threats, enhancing community well-being.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$54.8M

Above

Industry Average

Funded Over

3 Rounds

Notable Investors:
Early VC funding comparison data is currently unavailable. We're working to provide this information soon!
Early VC Funding Comparison
Coming Soon

Benefits

Medical, dental, & vision insurance

Unlimited PTO

Paid parental leave

401k contribution

Home office stipend

Commuter benefits

Free meals

Growth & Insights and Company News

Headcount

6 month growth

↓ -10%

1 year growth

↑ 3%

2 year growth

↑ 17%
Leads on Trees
Sep 24th, 2024
Biobot Analytics Secures $30 Million in Funding to Revolutionize Public Health Monitoring Through Sewer Technology

Biobot Analytics has successfully raised an impressive $30 million in its latest funding round, a significant boost that will propel the company's mission to revolutionize public health monitoring through innovative sewage analysis technology.

Finsmes
Mar 8th, 2024
Biobot Closes $24M in Series B Funding

Biobot closes $24M in Series B funding.

BNN Bloomberg
Jan 3rd, 2024
Biobot Analytics Launches Unique Nationwide Wastewater Monitoring Program

Biobot Analytics Launches Unique Nationwide Wastewater Monitoring Program

PR Newswire
Dec 21st, 2023
Biobot Analytics Reaches Full Enrollment For Nida-Funded Nationwide Wastewater-Based Monitoring Program For High Risk Substances

CAMBRIDGE, Mass., Dec. 21, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, announced that the company has reached full enrollment for a nationwide program sponsored by the National Institute on Drug Abuse (NIDA) to conduct anonymous, population-level wastewater-based monitoring on drugs of use and misuse, and overdose reversal agents. This is the first program of its kind in the United States and follows a design similar to that of successful programs in the European Union and Australia.In less than two months, Biobot recruited 70 wastewater treatment facilities and their associated public health departments into the program, with interest surpassing the program limit. Participants span 43 states, 62 counties representing approximately 35 million Americans, and include a diverse mix of urban and rural communities of varying sizes, ranging from San Diego, CA to Laredo, TX.While few of these communities had previously tested wastewater for high-risk substances, all of them expressed a strong interest in utilizing wastewater data to better understand and prevent substance use disorder and overdose deaths. Throughout this process, Biobot was greeted with high levels of enthusiasm for this program from local officials looking for new and innovative ways to limit the deadly impact of fentanyl and similar substances.In announcing the City of San Francisco's participation in this initiative , Dr. Hillary Kunins, SFDPH Behavioral Director, explained: "We need all the tools available to identify the presence of substances that may be used to halt and reverse this deadly epidemic

PR Newswire
Nov 1st, 2023
Lieutenant General H.R. Mcmaster Joins Biobot Analytics' Board Of Advisors

Former U.S. National Security Advisor joins Biobot to help grow its national security strategyCAMBRIDGE, Mass., Nov. 1, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, today announced that Lieutenant General H.R. McMaster, Former U.S. National Security Advisor, has joined the company's Board of Advisors. Lt

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for BioBot Analytics right now.

Find jobs on Simplify and start your career today

💡
We update BioBot Analytics's jobs every 8 hours, so check again soon! Browse all jobs →